Literature DB >> 9713080

[Value of pericardial biopsy in the etiologic diagnosis of pericardial diseases].

F Fernandes1, B M Ianni, E Arteaga, L Benvenutti, C Mady.   

Abstract

PURPOSE: To determine the value of pericardial biopsy as a complementary exam in the etiology of pericardial effusion.
METHODS: We analyzed retrospectively (from 1990 to 1997) 38 patients with pericardial effusion. The age ranged between 3 months and 79 years (mean 41.15 +/- 21.78 years). Pericardial biopsy was performed in all cases through a subxiphoid incision.
RESULTS: In 4 patients (10.5%) the biopsy was able to define etiology, 2 had tuberculosis and 2 neoplasias (1 undetermined adenocarcinoma, 1 mesotelioma). In 34 patients the biopsy showed non-specific chronic pericarditis.
CONCLUSION: Pericardial biopsy was not an effective method to determine the etiological diagnosis in pericardial effusion patients. We believe that we have to individualize the indication of pericardial biopsy especially if tuberculosis or neoplasia are suspected.

Entities:  

Mesh:

Year:  1998        PMID: 9713080     DOI: 10.1590/s0066-782x1998000600003

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  2 in total

1.  Subxiphoid pericardiostomy in the management of pericardial effusions: case series analysis of 368 patients.

Authors:  N Becit; Y Unlü; M Ceviz; C U Koçogullari; H Koçak; Y Gürlertop
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

2.  The role of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in the differential diagnosis of pericardial disease.

Authors:  Cheol Won Hyeon; Hyun Kyung Yi; Eun Kyoung Kim; Sung-Ji Park; Sang-Chol Lee; Seung Woo Park; Jae K Oh; Joon Young Choi; Sung-A Chang
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.